Sesamin inhibits RANKL-induced osteoclastogenesis and attenuates LPS-induced osteolysis via suppression of ERK and NF-κB signalling pathways.
Journal Information
Full Title: J Cell Mol Med
Abbreviation: J Cell Mol Med
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Molecular Biology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"CONFLICT OF INTEREST STATEMENT The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."
"FUNDING INFORMATION This work was supported by the National Natural Science Foundation (Grant No. 81860405: 82301001); Chinese Medicine Science and Technology Program of Jiangxi Province (Grant No. 2023B1217); Natural Science Foundation of Jiangxi Province (Grant No. 20232BAB206052: 20202BABL206037) and The First Affiliated Hospital of Nanchang University young talents research and Cultivation fund (Grant No. YFYPY202249)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025